New data from the pivotal phase 3 Checkmate 214 trial combining ipilumimab and nivolumab presented at the European Society of Medical Oncology (ESMO) conference in Madrid showed superiority for the combination over Sunitinib (Sutent). This data will likely mean that the IO combination will move to approval for first line stage 4 RCC therapy.
The Kidney Cancer Research Alliance (KCCure) announced today that their first research grant of $100,000 has been awarded to Dr. Wayne Marasco, at Dana Farber Cancer Center for his proposal: CAR T-Cell Factories that change the Tumor Microenvironment to Achieve RCC Cures.
For our part, in honor of World Kidney Cancer Day – we are proud to announce that our first grant of $100,000 is being awarded to Dr. Wayne Marasco at Dana Farber Cancer Center for his continuing efforts to translate CAR T-Cell Therapy into a new treatment for kidney cancer.
As members of the International Kidney Cancer Coalition (IKCC), KCCure is a proud partner and participant of the first-ever World Kidney Cancer Q&A Day. On June 22, 2017, patients, caregivers, health care professionals and local organizations from around the world will join together to raise awareness about kidney cancer.
Help us improve surveillance in kidney cancer by taking the KCCure kidney cancer survey
It's hard to believe how far we've come as an organization in less than one year since our launch. This week, marked another milestone as KCCure was represented, for the first time, at the International Kidney Cancer Coalition Conference (IKCC) in Warsaw, Poland.
Laura tells KCCure about her diagnosis with stage 4 papillary kidney cancer and how she now has No Evidence of Disease (NED) from the treatment Cabozantinib. This is her story.
Holly and Joe share a story that is familiar to many of us who have experienced a kidney cancer diagnosis. Delays due to the wrong tests, referrals for complications. But also what it means to patients when doctors communicate effectively and when nurses go above and beyond to save Christmas. Holly and Joe - we are all here cheering you on!
KCCure President Dena Battle shares her thoughts on caregiving and grief - and why even after a tough kidney cancer battle, she's still grateful for the past and hopeful for the future.
Holly Johnson, is a stage 4 kidney cancer patient, but she doesn't let herself be defined by her diagnosis. Thank you for lending your voice
I’ll be honest, there’s something about the word “awareness” that I’ve never really liked – I think it’s because I wish we didn’t have to be aware of kidney cancer. And I suppose it makes sense, because our goal at KCCure is to raise money for research to eliminate kidney cancer – to end the need for an awareness month. But for now, there are too many reminders that it sti...
ASCO GU is an annual symposium where doctors and members of the cancer community gather from around the world to discuss the latest and greatest in research for Genitourinary (GU) Cancers – which includes kidney cancer. KCCure was honored to be included, along with many other valued advocacy organizations, representing the patient voice.